OLEMA ONCOLOGY
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. The company focuses on the discovery, development, and commercialization of targeted therapies for women's cancers. It leverages the knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development. Olema leverages their deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance with the goal of transforming the standard of care for pre- and post-menopausal women living with cancer by developing more convenient and effective therapies.
OLEMA ONCOLOGY
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2007-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.olema.com
Total Employee:
11+
Status:
Active
Contact:
4157428265
Email Addresses:
[email protected]
Total Funding:
145.05 M USD
Technology used in webpage:
Google Font API Font Awesome Mobile Non Scaleable Content Nginx DigiCert SSL Digital Ocean RapidSSL Nginx 1.17
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Series C - Olema Oncology
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Olema Oncology
Deerfield
Deerfield investment in Series C - Olema Oncology
Avoro Capital Advisors
Avoro Capital Advisors investment in Series C - Olema Oncology
Wellington Management
Wellington Management investment in Series C - Olema Oncology
RA Capital Management
RA Capital Management investment in Series C - Olema Oncology
Venrock
Venrock investment in Series C - Olema Oncology
BVF Partners
BVF Partners investment in Series C - Olema Oncology
Logos Capital
Logos Capital investment in Series C - Olema Oncology
Vivo Capital
Vivo Capital investment in Series C - Olema Oncology
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-31 | Olema Oncology Appoints Naseem Zojwalla, M.D., as Chief Medical Officer |
Official Site Inspections
http://www.olema.com Semrush global rank: 2.41 M Semrush visits lastest month: 7.51 K
- Host name: 107.55.224.35.bc.googleusercontent.com
- IP address: 35.224.55.107
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Olema Oncology"
Olema Oncology - Crunchbase Company Profile
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. The company focuses on the discovery, development, and commercialization of …See details»
Olema Oncology – A cancer medicines company
Olema is a cancer medicines company. We are on a mission to elevate patient care in breast cancer and beyond. With nearly 2 million new diagnoses annually, breast cancer is the second …See details»
Org Chart Olema Oncology - The Official Board
Organizational Chart of Olema Oncology. Olema Oncology www.olema.com. has 27 executives +1 415 742 8265; Add an executive. Olema Oncology (OLMA) News . Anything missing? We …See details»
Olema Oncology Company Profile | Management and Employees …
SQL International Organization for Standardization . Human Resource Management Systems (3 Technologies) ADP TotalSource ADP . ADP ADP . BambooHR BambooHR . Web Content …See details»
Olema Oncology - Org Chart, Teams, Culture & Jobs - The Org
Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. Their lead program, OP-1250, a potential best-in-class complete estrogen …See details»
FAQs - Olema Oncology
Olema’s common stock began trading on The Nasdaq Global Select Market public on November 19, 2020. On which exchange is Olema listed and what is the ticker symbol? Olema's common …See details»
Olema Oncology Company Profile - Office Locations, Competitors …
Oct 29, 2024 Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies …See details»
Olema Oncology - Funding, Financials, Valuation & Investors
Olema Oncology is registered under the ticker NASDAQ:OLMA . Their stock opened with $19.00 in its Nov 19, 2020 IPO. Stock Symbol NASDAQ:OLMA ; Valuation at IPO $731.9M; Money …See details»
OLEMA PHARMACEUTICALS INC
The purpose of the Audit Committee (the “Committee”) of the Board of Directors of Olema Pharmaceuticals, Inc. (the “Company”) is to: • oversee the Company’s accounting and …See details»
Olema Oncology - Contacts, Employees, Board Members
Organization. Olema Oncology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 8. Number of …See details»
Olema Oncology – Join our team and make your mark
Olema is committed to cultivating an open, flexible, and supportive work environment with competitive compensation and benefits. We empower our team members and provide a …See details»
Olema Oncology - Overview, News & Similar companies - ZoomInfo
Feb 7, 2023 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN FRANCISCO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. …See details»
Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare ...
3 hours ago About Olema Oncology Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients …See details»
Olema Oncology – Better medicines for breast cancer and beyond …
SAN FRANCISCO, March 09, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company …See details»
Olema - Crunchbase Company Profile & Funding
Olema is located in San Francisco, California, United States. Who are Olema 's competitors? Alternatives and possible competitors to Olema may include Gokomodo and Datayak .See details»
Olema Oncology - Company Profile & Staff Directory - ContactOut
Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. Our lead program, OP-1250, a potential best-in-class complete estrogen …See details»
Mission, Vision & Core Values of Olema Oncology – CBM
Oct 2, 2024 Olema Oncology is a company dedicated to transforming the landscape of cancer treatment through innovation and dedication to improving patient outcomes. Our mission is to …See details»
Olema Oncology – Better medicines for breast cancer and beyond …
Dec 2, 2024 Olema well capitalized to fund operations beyond key milestones including OPERA-01 Phase 3 top-line data in 2026, initial OP-3136 KAT6 Phase 1/2 monotherapy and …See details»
Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare …
3 hours ago SAN FRANCISCO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical …See details»
Olema Pharmaceuticals to Present at 43rd Annual J.P. Morgan
3 hours ago Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast …See details»